Pernilla Abrahamsson
Chief Operating Officer at LIPUM AB
Profile
Pernilla Abrahamsson is the founder of MD Biomedical AB.
She is currently the Chief Operating Officer at Lipum AB.
Previously, she worked as Manager-Product Development at Senzime AB from 2018 to 2019.
Dr. Abrahamsson obtained a doctorate degree from Umea Universitet.
Pernilla Abrahamsson active positions
| Companies | Position | Start |
|---|---|---|
| LIPUM AB | Chief Operating Officer | 2018-12-31 |
Former positions of Pernilla Abrahamsson
| Companies | Position | End |
|---|---|---|
| SENZIME AB | Corporate Officer/Principal | 2019-03-31 |
MD Biomedical AB
 MD Biomedical AB Medical/Nursing ServicesHealth Services Part of Senzime AB, MD Biomedical AB provides micro dialysis products and services. The company is based in Umeå, Sweden. The Swedish company was founded in 2011 by Pernilla Abrahamsson. MD Biomedical was acquired by Senzime AB on April 21, 2015 for $0.24 million. | Founder | - |
Training of Pernilla Abrahamsson
| Umea Universitet | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| SENZIME AB | Health Technology |
| LIPUM AB | Health Technology |
| Private companies | 1 |
|---|---|
MD Biomedical AB
MD Biomedical AB Medical/Nursing ServicesHealth Services Part of Senzime AB, MD Biomedical AB provides micro dialysis products and services. The company is based in Umeå, Sweden. The Swedish company was founded in 2011 by Pernilla Abrahamsson. MD Biomedical was acquired by Senzime AB on April 21, 2015 for $0.24 million. | Health Services |
- Stock Market
- Insiders
- Pernilla Abrahamsson
